ZBH

Zimmer Biomet Holdings Inc
NYSEHEALTHCAREMEDICAL DEVICES

Key Statistics

Market Cap
$18.00B
P/E Ratio
22.91
EPS
$4.12
Beta
0.48
52W High
$105.75
52W Low
$78.70
50-Day MA
$95.32
200-Day MA
$91.37
Dividend Yield
1.05%
Profit Margin
9.48%
Forward P/E
10.05
PEG Ratio
0.57

About Zimmer Biomet Holdings Inc

Zimmer Biomet is a publicly traded medical device company. The company is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$8.51B
Gross Profit (TTM)$5.92B
EBITDA$2.52B
Operating Margin18.00%
Return on Equity6.41%
Return on Assets3.88%
Revenue/Share (TTM)$43.50
Book Value$66.23
Price-to-Book1.37
Price-to-Sales (TTM)2.12
EV/Revenue2.868
EV/EBITDA10.47
Quarterly Earnings Growth (YoY)33.80%
Quarterly Revenue Growth (YoY)4.80%
Shares Outstanding$190.74M
Float$190.13M
% Insiders0.16%
% Institutions111.33%

Historical Volatility

HV 10-Day
30.83%
HV 20-Day
29.02%
HV 30-Day
31.17%
HV 60-Day
28.54%
HV Rank
61.9%

Volatility is currently contracting

Analyst Ratings

Consensus ($106.82 target)
3
Strong Buy
6
Buy
18
Hold

Latest News

Should Value Investors Buy Zimmer Biomet (ZBH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research10/12/2026Positive
Zimmer Biomet - Showing Signs Of Life

Zimmer Biomet is seeing structural constant currency sales growth appear. This is driven by transformation factors, R&D and M&A efforts. Earnings growth is lagging sales, but this hopefully should catch up soon.

Seeking Alpha9/1/2026Positive
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2026

WARSAW, Ind., Aug. 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2026.

PRNewsWire8/28/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ZBH and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 10/17/2026